Page last updated: 2024-08-24

2,4-diaminoquinazoline and Cancer of Stomach

2,4-diaminoquinazoline has been researched along with Cancer of Stomach in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chan, MWY; Chang, TS; Chen, WM; Chiang, MK; Hsieh, YY; Lu, CK; Tung, SY; Wei, KL; Wu, CS	1

Other Studies

1 other study(ies) available for 2,4-diaminoquinazoline and Cancer of Stomach

Article	Year
2,4-Diamino-Quinazoline, a Wnt Signaling Inhibitor, Suppresses Gastric Cancer Progression and Metastasis. International journal of molecular sciences, 2020, Aug-17, Volume: 21, Issue:16 Topics: Aged; Animals; Antineoplastic Agents; Apoptosis; Axin Protein; Cell Line; Cell Line, Tumor; Cells, Cultured; Female; Humans; Lymphoid Enhancer-Binding Factor 1; Male; Mice; Mice, Nude; Middle Aged; Neoplasm Metastasis; Proto-Oncogene Proteins c-myc; Quinazolines; Receptors, G-Protein-Coupled; Stomach Neoplasms; Wnt Signaling Pathway	2020

Article

Year

2,4-Diamino-Quinazoline, a Wnt Signaling Inhibitor, Suppresses Gastric Cancer Progression and Metastasis.

International journal of molecular sciences, 2020, Aug-17, Volume: 21, Issue:16

Topics: Aged; Animals; Antineoplastic Agents; Apoptosis; Axin Protein; Cell Line; Cell Line, Tumor; Cells, Cultured; Female; Humans; Lymphoid Enhancer-Binding Factor 1; Male; Mice; Mice, Nude; Middle Aged; Neoplasm Metastasis; Proto-Oncogene Proteins c-myc; Quinazolines; Receptors, G-Protein-Coupled; Stomach Neoplasms; Wnt Signaling Pathway

2020